86
Views
19
CrossRef citations to date
0
Altmetric
Clinical Focus: ADHD, Allergies, and Immunization

The Single-Dose Pharmacokinetics of NWP06, a Novel Extended-Release Methylphenidate Oral Suspension

, MD & , MD, PhD
Pages 35-41 | Published online: 13 Mar 2015

References

  • . Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921
  • . Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(4):1033–1044
  • . Merikangas KRR, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS. Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES. Pediatrics. 2010;125(1):75–81
  • . Solanto MV, Pope-Boyd SA, Tryon WW, Stepak B. Social functioning in predominantly inattentive and combined subtypes of children with ADHD. J Atten Disord. 2009;13(1):27–35
  • . Loe IM, Feldman HM. Academic and educational outcomes of children with ADHD. J Pediatr Psychol. 2007;32(6):643–654
  • . A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073–1086
  • . ParentsMedGuide.org. ADHD parent's medication guide. 2007
  • . Information from your family doctor. ADHD in Children. Am Fam Physician. 2009;78(8):1
  • . Cascade E, Kalali AH, Weisler RH. Short-acting versus long-acting medications for the treatment of ADHD. Psychiatry (Edgmont). 2008;5(8):24–27
  • . Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can J Clin Pharmacol. 2006;13(1):e50–e62
  • . Meltzer EO, Welch MJ, Ostrom NK. Pill swallowing ability and training in children 6 to 11 years of age. Clin Pediatr (Phila). 2006;45(8):725–733
  • . Findling RL, Wigal SB, Bukstein OG, . Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials. Clin Ther. 2009;31(8):1844–1855
  • . US Food and Drug Administration. Food and Drug Administration Amendments Act of 2007. 2007:44–45
  • . US Food and Drug Administration. Guidance for Industry: General Considerations for Pediatric Pharmacokinetic Studies for Drugs and Biological Products. 1998
  • . Srinivas NR, Hubbard JW, Quinn D, Midha KK. Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder. Clin Pharmacol Ther. 1992;52(5):561–568
  • . Aoyama T, Kotaki H, Sasaki T, Sawada Y, Honda Y, Iga T. Nonlinear kinetics of threo-methylphenidate enantiomers in a patient with narcolepsy and in healthy volunteers. Eur J Clin Pharmacol. 1993;44(1):79–84
  • . Gibaldi M, Perrier D. Pharmacokinetics. Ed 2. New York, NY: Marcel Dekker, Inc; 1982
  • . Posner K, Oquendo MA, Gould M, Stanley B, Davies M. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007;164(7):1035–1043
  • . Adderall XR [package insert]. Wayne, PA: Shire US Inc; 2007
  • . Ritalin LA [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2006
  • . Metadate CD [package insert]. Smyrna, GA: UCB, Inc; 2006
  • . Focalin XR [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2009
  • . Vyvanse [package insert]. Wayne, PA: Shire US Inc; 2010
  • . Daytrana [package insert]. Wayne, PA: Shire US Inc; 2008
  • . Srinivas NR, Hubbard JW, Korchinski ED, Midha KK. Enantioselective pharmacokinetics of dl-threo-methylphenidate in humans. Pharm Res. Jan 1993;10(1):14–21
  • . Wigal SB, Wigal TL. The laboratory school protocol: its origin, use, and new applications. J Atten Disord. 2006;10(1):92–111
  • . Wigal SB, Kollins SH, Childress AC, Squires L. A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatry Ment Health. 2009;3(1):17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.